Nektar Therapeutics
NKTR · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$119 | -$276 | -$368 | -$524 |
| Dep. & Amort. | $4 | $8 | $13 | $14 |
| Deferred Tax | $0 | -$0 | $3 | $8 |
| Stock-Based Comp. | $22 | $33 | $57 | $95 |
| Change in WC | -$6 | -$20 | $0 | -$23 |
| Other Non-Cash | -$77 | $62 | -$9 | $17 |
| Operating Cash Flow | -$176 | -$193 | -$304 | -$413 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$1 | -$1 | -$6 | -$15 |
| Net Acquisitions | $65 | $0 | $13 | -$218 |
| Inv. Purchases | -$262 | -$512 | -$468 | -$961 |
| Inv. Sales/Matur. | $340 | $651 | $826 | $1,178 |
| Other Inv. Act. | $0 | $1 | $0 | $218 |
| Investing Cash Flow | $143 | $140 | $366 | $203 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $0 | $0 | $1 | $33 |
| Stock Repurch. | -$3 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $45 | $0 | $1 | $3 |
| Financing Cash Flow | $42 | $0 | $2 | $36 |
| Forex Effect | -$0 | $0 | -$0 | -$0 |
| Net Chg. in Cash | $9 | -$53 | $63 | -$174 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $35 | $88 | $25 | $199 |
| End Cash | $44 | $35 | $88 | $25 |
| Free Cash Flow | -$177 | -$193 | -$310 | -$428 |